Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switzerland. He explains why many brands misunderstand the German-speaking market: distribution and pharmacy listings alone do not create demand, pharmacies are not straightforward sales channels, and sceptical consumers require multiple trust-building touchpoints before making a purchase.

The conversation explores the practical realities of regulation, market access and enforcement, the differences between brick-and-mortar and online pharmacies, and why many market entries fail when companies focus on sales projections rather than customer acquisition and long-term retention. Gielow also discusses the challenges of consumer education, the influence of misinformation on social media, and the widening gap between rigorous scientific evidence and the content that attracts the greatest online attention.

Finally, he argues that prevention remains undervalued across healthcare systems and that longevity does not have to depend on expensive interventions. Instead, he makes the case for focusing on the fundamentals: regular movement, good nutrition, quality sleep, strong relationships, and learning to listen to the body’s signals.

https://www.mentry-pharma.com/

https://www.linkedin.com/in/robertgielow/

00:00 Welcome and Episode Setup

02:16 Meet Robert and Mentory Pharma

04:18 How Mentory Pharma Started

08:31 Why Distribution Alone Fails

11:04 Pharmacies Aren't Salespeople

13:59 Why Brands Fail in Germany

19:12 Regulation Reality Check

25:39 Influencers vs Real Science

28:17 What Even Is Longevity

28:42 Vitamin D Rules Clash

31:09 Enforcement Reality Check

32:49 Why Prevention Lags

35:39 Pharma Shifts to Prevention

38:07 Markets Ahead of Europe

43:25 Longevity for the Rich

46:08 Back to Simple Habits

50:34 Building Credible Brands

55:26 Rapid Fire Takeaways

57:55 Closing Reflections

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Longevity medicine has created a strange new kind of patient: the healthy person convinced something must be wrong.A wearable flags poor recovery. One test says your body is ageing faster than it shou...

20 Syys 1h

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

At 16, Chris Mirabile was lying in a hospital bed the night before brain surgery, wondering whether he would wake up the next morning. Years later, as he was building NOVOS, he lost his mother to panc...

13 Syys 1h 14min

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Recorded at HLTH Europe in Amsterdam, Part Two of our special series looks at four very different ways technology could help healthcare move earlier, become more personalised and make better use of th...

6 Syys 57min

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

What happens when technology stops simply tracking our health and starts helping us understand what to do about it?Recorded at HLTH Europe in Amsterdam, this episode of Beyond Longevity features three...

30 Elo 42min

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

What if a vaccine could help the immune system clear senescent “zombie” cells — damaged cells linked to ageing, chronic inflammation and age-related disease?In this episode of Beyond Longevity, Daphna...

23 Elo 56min

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Elo 1h 6min

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Elo 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Elo 48min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-hereilla
tiedekulma-podcast
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
hippokrateen-vastaanotolla
rss-bios-podcast
docemilia
rss-politiikasta-podcast
rss-tiedetta-vai-tarinaa
rss-ranskaa-raakana
rss-lihavuudesta-podcast
radio-antro
rss-radplus